3Peghini PL, Katz PO, Castell DO. Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects. Gastroenterology, 1998,115 : 1335-1339.
4Xue S, Katz PO, Banerjee P, et al. Bedtime Hz blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors. Aliment Pharmacol Ther, 2001,15 : 1351-1356.
5Nzeako UC, Murray JA. An evaluation of the clinical implications of acid breakthrough in patients on proton pump inhibitor therapy. Aliment Pharmacol Ther, 2002,16 : 1309-1316.
6Hatlebakk JG, Katz PO, Camacho-Lobato L, et al. Proton pump inhibitors: better acid suppression when taken be[ore a meal than without a meal. Aliment Pharmacol Ther, 2000,14:1267-1272.
7Fackler WK, Ours TM, Vaezi MF, et al. Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough. Gastroenterology, 2002,122 :625-632.
8Haggitt RC. Histopathology of reflux-induced esophageal and supraesophageal injuries. AM J Med ,2000,108 ( Suppl 4a) : 1095-1115.
9Kim R, Clarke MR, Melhem MF, et al. Expression of p53, PCNA, and C- erbB2 in Barrett' s metaplasia and adenoeareinoma. Dig Dis Sci, 1997, 42:2453.
10Kihara C, Seki T, Funkawa Y, et al. Mutations in zincbinding domain of p53 as a prognostic marker of esophageal cancer patients. Jpn J Cancer Res,2000,91 : 190-198.
